EUVIMEDEUVIMED entdecken
Crossref

Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment

P Schenk, M Schöni, L Urbanschitz, L Filli, S Rahm, P Zing

Acta Orthopaedica Belgica · 30.03.2023 · 89 (1) · 65-69

DOI: 10.52628/89.1.10424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Orthopaedica Belgica, 2023-06. Verfasst von P Schenk und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tenosynovial Giant Cell Tumor (TSGCT) or formerly pigmented villonodular synovitis (PVNS) is a rare nonmalignant tumor of the synovia seldom affecting the hip. MRI and surgical resection are the gold standards in its diagnosis and treatment. However, the accuracy of MRI is unknown, and only few reports on its surgical treatment results exist. The goal of the study was to investigate the MRI accuracy, results after surgical treatment, and natural history of untreated MRI-diagnosed hip TSGCT. Twenty-four consecutive patients with suspected TSGCT on hip MRI, between December 2006 and January 2018, were identified from our medical database. Six refused to participate. About 18 patients with a minimal follow-up of 18 months were enrolled. Charts were reviewed for histopathology results, specific treatment and recurrence. At the last follow-up, all patients had a clinical (Harris Hip Score [HHS]) and radiological examination (x-ray and MRI). Out of 18 patients with suspected TSGCT on MRI, with a mean age of 35y (range 17-52), 14 had surgi- cal resection and 4 refused surgery 1 of whom had a CT-guided biopsy. Out of 15 cases with biopsies, in 10 TSGCT was confirmed. Three surgically-treated patients showed recurrence on MRI after 24, 31 and 43 months. Two non-treated patients showed progression after 18 and 116 months. At the last follow-up (65 m; range 18-159), the mean HHS with or without recurrence was 90 and 80pts (ns). Operative vs. non-operative treatment showed HHS of 86 and 90pts (ns). In the conservatively-treated group, HHS with and without progression was 98 and 82pts (ns), respectively. MRI-suspected TSGCT of the hip was confirmed with biopsy in two-thirds of the cases. Surgical treatment showed recurrence in more than one-third of the patients. Two out of four untreated patients showed progression of the TSGCT-suspected lesion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell Tumor of Tendon SheathSynovitis, Pigmented VillonodularHumansAdultBiopsyTreatment OutcomeMagnetic Resonance Imaging

Zitieren

APA

Schenk, P., Schöni, M., Urbanschitz, L., Filli, L., Rahm, S., & Zing, P. (2023). Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment. Acta Orthopaedica Belgica, 89(1), 65-69. https://doi.org/10.52628/89.1.10424

Vancouver

Schenk P, Schöni M, Urbanschitz L, Filli L, Rahm S, Zing P. Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment. Acta Orthopaedica Belgica. 2023;89(1):65-69. doi:10.52628/89.1.10424

BibTeX
@article{Schenk2023,
  author = {Schenk, P and Schöni, M and Urbanschitz, L and Filli, L and Rahm, S and Zing, P},
  title = {Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment},
  journal = {Acta Orthopaedica Belgica},
  year = {2023},
  volume = {89},
  number = {1},
  pages = {65--69},
  doi = {10.52628/89.1.10424}
}
Kostenlos starten →